---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-104741"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2023-09-28T23:59:59+00:00"
generated_at: "2026-06-10T07:37:08.698813+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Board member John Nosenzo resigns from TELA Bio board effective Sept 22, 2023

## Summary
- John Nosenzo resigned from TELA Bio's Board of Directors on September 22, 2023.
- He also resigned from the Audit and Nominating and Corporate Governance Committees.
- Resignation not due to any disagreement with the Company's operations, policies, or practices.
- No replacement director has been announced as of the filing date.

## SEC filing metadata
- accession: 0001104659-23-104741
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2023-09-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465923104741/0001104659-23-104741-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465923104741/tm2326994d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-104741
- JSON: https://secwatch.observer/filing/0001104659-23-104741.json
- Plain text: https://secwatch.observer/filing/0001104659-23-104741.txt

## Key facts
- Executive change
  John Nosenzo resigned as Director at TELA Bio, Inc..
  - Action: resigned
  - Role: Director
  source text: On September 22, 2023, John Nosenzo, a member of the Board of Directors (the “Board”) of TELA Bio, Inc. (the “Company”), tendered his resignation from the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1561921/000110465923104741/0001104659-23-104741-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.